🔎 Trials Near Me

Home › Mga Degenerative Nerve Disease › Massachusetts

Pag-aaral pangklinika para sa Mga Degenerative Nerve Disease sa Massachusetts

6 pag-aaral para sa Mga Degenerative Nerve Disease ang naghahanap ng mga kalahok sa mga site sa Massachusetts.

Mga Lungsod sa Massachusetts

Opisyal na teksto ng pag-aaral (English)

A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)

  • Massachusetts General Hospital - Charlestown, Charlestown
  • K2 Medical Research - Foxborough, Foxborough
  • Neurology Center of New England, Foxborough
  • at 1 pa
Nagre-recruitPhase 2
Edad 55 hanggang 85 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07589595

A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease

  • Massachusetts General Hospital (MGH), Charlestown
Nagre-recruitPhase 1
Edad 50 hanggang 85 · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT06297590

An Open-Label Exploratory Study of Fosigotifator in Participants With Vanishing White Matter Disease

  • Massachusetts General Hospital /ID# 270960, Boston
Nagre-recruitPhase 1/2
6 Months · Lahat ng kasarian · Na-update Okt 19, 2026 · NCT05757141

PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort

  • Boston University, Boston
  • Massachusetts General Hospital, Boston
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 30 pataas · Lahat ng kasarian · Na-update Hul 27, 2026 · NCT04477785

Hereditary Spastic Paraplegia Genomic Sequencing Initiative (HSPseq)

  • Boston Children's Hospital, Boston
Nagre-recruitObservasyonal na pag-aaral
1 Month – 30 Years · Lahat ng kasarian · Na-update Mar 18, 2026 · NCT05354622

Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside

  • McLean Hospital, Belmont
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 89 · Lahat ng kasarian · Na-update Nob 6, 2025 · NCT05245903

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.